{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:51:39Z","timestamp":1770893499946,"version":"3.50.1"},"reference-count":42,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2012,11,7]],"date-time":"2012-11-07T00:00:00Z","timestamp":1352246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Scand J Immunol"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The development of clinically relevant biomarkers is important for diagnosing latent tuberculosis infection (<jats:styled-content style=\"fixed-case\">LTBI<\/jats:styled-content>) and active tuberculosis (<jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content>) and predicting their prognoses. This study examined whether the responses of multiple cytokines can be used as a biomarker to distinguish the <jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> infection status and mycobacterial load. We analysed the responses of multiple cytokines (<jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010\u03b3, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20102, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201010, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201013, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201017 and <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>\u2010\u03b1) in the supernatant from the Quanti<jats:styled-content style=\"fixed-case\">FERON<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">TB G<\/jats:styled-content>old <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>n\u2010<jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>ube assay following stimulation of whole blood from the <jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> group (<jats:italic>n<\/jats:italic>\u00a0=\u00a032), <jats:styled-content style=\"fixed-case\">LTBI<\/jats:styled-content> group (<jats:italic>n<\/jats:italic>\u00a0=\u00a019) and healthy controls (<jats:italic>n<\/jats:italic>\u00a0=\u00a030) with <jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> antigens (<jats:styled-content style=\"fixed-case\">ESAT<\/jats:styled-content>\u20106, <jats:styled-content style=\"fixed-case\">CFP<\/jats:styled-content>\u201010 and <jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content>7.7). The median responses of <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010\u03b3, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20102, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201010 and <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201013 were higher in the <jats:styled-content style=\"fixed-case\">LTBI<\/jats:styled-content> and active <jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> groups than in the non\u2010<jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> control group (<jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010\u03b3, <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.001; <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20102, <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.001; <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201010, <jats:italic>P<\/jats:italic>\u00a0=\u00a00.012; <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201013, <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.001). The median <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20102\/<jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010\u03b3 ratio of the <jats:styled-content style=\"fixed-case\">LTBI<\/jats:styled-content> group was higher than that of the active <jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> group (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.014) and differed significantly between patients with <jats:styled-content style=\"fixed-case\">LTBI<\/jats:styled-content>, patients with smear\u2010negative <jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> and patients with smear\u2010positive <jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.027). This difference was especially evident between the patients with <jats:styled-content style=\"fixed-case\">LTBI<\/jats:styled-content> and patients with smear\u2010positive <jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.047). In conclusion, <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010\u03b3, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20102, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201010 and <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201013 can serve as biomarkers for distinguishing <jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> infection. In addition, the <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20102\/<jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010\u03b3 ratio appears to be a biomarker for diagnosing <jats:styled-content style=\"fixed-case\">LTBI<\/jats:styled-content> and may be useful as a prognostic factor and for evaluating treatment responses.<\/jats:p>","DOI":"10.1111\/j.1365-3083.2012.02776.x","type":"journal-article","created":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T10:00:33Z","timestamp":1346839233000},"page":"580-586","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["The Responses of Multiple Cytokines Following Incubation of Whole Blood from <scp>TB<\/scp> Patients, Latently Infected Individuals and Controls with the <scp>TB<\/scp> Antigens <scp>ESAT<\/scp>\u20106, <scp>CFP<\/scp>\u201010 and <scp>TB<\/scp>7.7"],"prefix":"10.1111","volume":"76","author":[{"given":"S. Y.","family":"Kim","sequence":"first","affiliation":[{"name":"Division of Pulmonology Department of Internal Medicine Yonsei University College of Medicine Seoul Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. S.","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Pulmonology Department of Internal Medicine Yonsei University College of Medicine Seoul Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. S.","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Pulmonology Department of Internal Medicine Yonsei University College of Medicine Seoul Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. K.","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Pulmonology Department of Internal Medicine Yonsei University College of Medicine Seoul Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Pulmonology Department of Internal Medicine Yonsei University College of Medicine Seoul Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. J.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Microbiology Yonsei University College of Medicine Seoul Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.\u2010N.","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Microbiology Yonsei University College of Medicine Seoul Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. A.","family":"Kang","sequence":"additional","affiliation":[{"name":"Division of Pulmonology Department of Internal Medicine Yonsei University College of Medicine Seoul Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,11,7]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.3109\/1354750X.2011.628048"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2007.07.001"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1086\/529049"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011110"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1086\/341314"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1449"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012365"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2011.02.006"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009051"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.05013-11"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.6.2249"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199612263352602"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(95)90001-2"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201040455"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.3.1962"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.1997.tb01046.x"},{"key":"e_1_2_7_18_1","first-page":"479","article-title":"Increased Th1 and Th2 type cytokine production in patients with active tuberculosis","volume":"9","author":"Handzel ZT","year":"2007","journal-title":"Isr Med Assoc J"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.07.022"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.2174\/156652407780598557"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxq429"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1086\/519266"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00364-07"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02403-07"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-5-200803040-00003"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2008.02217.x"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838693"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.03104.x"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200909-1463OC"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2011.02.002"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-008-0497-5"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200205-438BC"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri1840"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015619"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.8.5217"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/44385"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.290.5489.92"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1086\/381679"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.6.3314-3321.2000"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1086\/314640"},{"key":"e_1_2_7_41_1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1684\/ecn.2009.0182","article-title":"T cells co\u2010producing Mycobacterium tuberculosis\u2010specific type 1 cytokines for the diagnosis of latent tuberculosis","volume":"21","author":"Nemeth J","year":"2010","journal-title":"Eur Cytokine Netw"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00055508"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-9-21"}],"container-title":["Scandinavian Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3083.2012.02776.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3083.2012.02776.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T07:35:49Z","timestamp":1698651349000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3083.2012.02776.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,7]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["10.1111\/j.1365-3083.2012.02776.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3083.2012.02776.x","archive":["Portico"],"relation":{},"ISSN":["0300-9475","1365-3083"],"issn-type":[{"value":"0300-9475","type":"print"},{"value":"1365-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,7]]},"assertion":[{"value":"2012-05-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-08-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-11-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}